STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

High Resolution Wavefront-guided vs. Wavefront Optimized LASIK

Not Applicable

Active, not recruiting

Conditions: Nearsightedness
Astigmatism

Interventions: Procedure: LASIK

First Posted Date: 2015-10-01

Last Posted Date: 2024-06-25

Lead Sponsor: Stanford University

Target Recruit Count: 100

Registration Number: NCT02565537

Locations: 🇺🇸
Stanford University School of Medicine, Palo Alto, California, United States

FDA Approved Medication to Reduce Binge Eating and/or Purging

Phase 1

Completed

Conditions: Bulimia Nervosa
Binge Eating Disorder

Interventions: Drug: Phentermine/Topiramate-First
Drug: Placebo

First Posted Date: 2015-09-18

Last Posted Date: 2018-05-14

Lead Sponsor: Stanford University

Target Recruit Count: 22

Registration Number: NCT02553824

Locations: 🇺🇸
Stanford School of Medicine, Psychiatry and Behavioral Sciences, Stanford, California, United States

Transciptomic Modification Induced by miRNAs in Endometrial Fluid

Not Applicable

Completed

Conditions: MicroRNA in Endometrial Fluid

Interventions: Procedure: Endometrial fluid aspiration

First Posted Date: 2015-09-18

Last Posted Date: 2018-04-20

Lead Sponsor: Stanford University

Target Recruit Count: 10

Registration Number: NCT02554539

Locations: 🇺🇸
Stanford University, Stanford, California, United States

Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers

Not Applicable

Completed

Conditions: Pressure Ulcer

Interventions: Other: Optimal Turning
Other: Standard Care Practices
Other: Patient Sensor

First Posted Date: 2015-08-27

Last Posted Date: 2018-04-09

Lead Sponsor: Stanford University

Target Recruit Count: 1312

Registration Number: NCT02533726

Locations: 🇺🇸
Stanford Health Care, Stanford, California, United States

Correlation Between Oocyte and Embryo Mechanical Properties on Embryo Development and Clinical Pregnancy After In Vitro Fertilization

Completed

Conditions: Infertility
Pregnancy, Multiple

Interventions: Procedure: EmbryoHug

First Posted Date: 2015-08-21

Last Posted Date: 2021-02-16

Lead Sponsor: Stanford University

Target Recruit Count: 119

Registration Number: NCT02530892

Locations: 🇨🇳
Taiwan IVF Group, Hsinchu, Taiwan
🇺🇸
Stanford University IVF clinic, Stanford, California, United States
🇨🇳
Shenzhen Army and Police Hospital--Reproductive Unit, Shenzhen, China

Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer

Not Applicable

Withdrawn

Conditions: Ovarian Carcinoma
Fallopian Tube Carcinoma

Interventions: Procedure: Photoacoustic Imaging

First Posted Date: 2015-08-21

Last Posted Date: 2018-11-28

Lead Sponsor: Stanford University

Registration Number: NCT02530606

Locations: 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States

Omega-3 Supplementation for Smell Dysfunction

Not Applicable

Completed

Conditions: Smell Dysfunction
Sellar/Parasellar Tumor

Interventions: Dietary Supplement: Omega-3

First Posted Date: 2015-08-20

Last Posted Date: 2018-08-21

Lead Sponsor: Stanford University

Target Recruit Count: 110

Registration Number: NCT02529332

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder

Phase 4

Completed

Conditions: Bipolar Disorder
Insomnia

Interventions: Drug: Suvorexant
Drug: Placebo

First Posted Date: 2015-08-19

Last Posted Date: 2022-10-06

Lead Sponsor: Stanford University

Target Recruit Count: 61

Registration Number: NCT02527564

Locations: 🇺🇸
Stanford University, Stanford, California, United States

On-Line Intervention to Lower Cardiovascular Risk in Pediatric Heart Transplant Patients

Not Applicable

Completed

Conditions: Physical Activity
Attitude to Health
Vascular; Change
Health Behavior
Dietary Modification

Interventions: Other: On-Line Diet and Exercise Intervention

First Posted Date: 2015-08-11

Last Posted Date: 2019-09-19

Lead Sponsor: Stanford University

Target Recruit Count: 14

Registration Number: NCT02519946

Locations: 🇺🇸
Stanford Children's Health, Palo Alto, California, United States

Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children

Phase 1

Completed

Conditions: Refractory Solid Tumors
Relapsed Leukemia
Relapsed Solid Tumors
Refractory Leukemia

Interventions: Drug: Carfilzomib
Drug: Cyclophosphamide
Drug: Etoposide

First Posted Date: 2015-07-31

Last Posted Date: 2024-01-12

Lead Sponsor: Stanford University

Target Recruit Count: 4

Registration Number: NCT02512926

Locations: 🇺🇸
Phoenix Children's Hospital, Phoenix, Arizona, United States
🇺🇸
Penn State Hershey Children's Hospital, Hershey, Pennsylvania, United States
🇺🇸
Stanford University School of Medicine and Stanford Cancer Institute, Palo Alto, California, United States

and more 5 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy